Category: pharma & healthcare

A study from the Imperial College of London suggests that people with Covid-19 should isolate themselves for a minimum of five days and safely exit depending on rapid antigen test results.

BA.5, the leading variant in the United States, contains intrinsic virological properties that give it an edge over other variants.

mRNA vaccine technology rose to prominence during the Covid-19 pandemic. But the same system can be used to combat other viruses, with the promise of quicker turnaround and cheaper manufacturing. Will the next influenza vaccine be an mRNA vaccine?

A study published in the journal Viruses seeks to understand what happens to T cell responses if the B cell defense of adaptive immunity is severely compromised.

Just as each face must be perfectly aligned to solve a Rubik’s Cube, each protein in SARS-CoV-2 must be ideally mutated in order to create a highly transmissible variant.

The device amplifies DNA from viruses which cause cancer to help pathologists diagnose and treat tumors faster.

A group of scientists at Harvard University has developed a new method to grow artificial hearts from scratch. This study serves as a significant stepping stone toward artificial hearts that are fully functional.

White women have the highest annual rise in diagnoses of advanced cervical cancer, which can often be detected earlier with regular screening.

The National Cancer Institute will award funding to four institutions to conduct research into telehealth applications for cancer care.

Although decent, our current influenza vaccines are not as effective as they ought to be. Part of the issue may have to do with the production process. Are recent changes enough to improve effectiveness?